As of Mar 24
| +0.09 / +1.78%|
The 2 analysts offering 12-month price forecasts for Starpharma Holdings Ltd have a median target of 6.45, with a high estimate of 7.57 and a low estimate of 5.33. The median estimate represents a +25.20% increase from the last price of 5.15.
The current consensus among 1 polled investment analysts is to Buy stock in Starpharma Holdings Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.